A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Teijin America, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05437419
- Locations
- 🇺🇸
San Marcus Research Clinic, Inc., Miami Lakes, Florida, United States
🇺🇸Allied Biomedical Research Institute, Miami, Florida, United States
🇺🇸Floridian Clinical Research, LLC, Miami Lakes, Florida, United States
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
- First Posted Date
- 2018-02-28
- Last Posted Date
- 2022-08-30
- Lead Sponsor
- Teijin America, Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT03449199
- Locations
- 🇺🇸
Aventiv Research Inc., Mesa, Arizona, United States
🇺🇸Comprehensive Research Institute, Alhambra, California, United States
🇺🇸California Kidney Specialists, San Dimas, California, United States
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
- First Posted Date
- 2013-11-08
- Last Posted Date
- 2020-02-11
- Lead Sponsor
- Teijin America, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01978912
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath